• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9介导的LINC00511基因敲除策略,通过抑制抗凋亡基因增加了乳腺癌细胞的凋亡。

CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes.

作者信息

Azadbakht Narjes, Doosti Abbas, Jami Mohammad-Saeid

机构信息

Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

出版信息

Biol Proced Online. 2022 Jul 5;24(1):8. doi: 10.1186/s12575-022-00171-1.

DOI:10.1186/s12575-022-00171-1
PMID:35790898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9254607/
Abstract

BACKGROUND

The growing detection of long noncoding RNAs (lncRNAs) required the application of functional approaches in order to provide absolutely precise, conducive, and reliable processed information along with effective consequences. We utilized genetic knockout (KO) techniques to ablate the Long Intergenic Noncoding RNA 00,511 gene in several humans who suffered from breast cancer cells and at the end we analyzed and examined the results.

RESULTS

The predictive relevance of LINC00511 expression pattern was measured by using a pooled hazard ratio (HR) with a 95% confidence interval (CI). The link among LINC00511 expression profiles and cancer metastasis was measured by using a pooled odds ratio (OR) with a 95% confidence interval. This meta- analysis was composed of fifteen studies which contained a total of 1040 tumor patients. We used three distinct CRISPR/Cas9-mediated knockdown techniques to prevent the LINC00511 lncRNA from being transcribed. RT-PCR was used to measure lncRNA and RNA expression. We used CCK-8, colony formation tests, and the invasion transwell test to measure cell proliferation and invasion. The stemness was measured by using a sphere-formation test. To validate molecular attachment, luciferase reporter assays were performed. The functional impacts of LINC00511 gene deletion in knockdown breast cancer cell lines were confirmed by using RT-qPCR, MTT, and a colony formation test. This meta-analysis was composed of 15 trials which contained a total of 1040 malignant tumors. Greater LINC00511 expression was ascribed to a lower overall survival (HR = 1.93, 95% CI 1.49-2.49, < P 0.001) and to an increased proportion of lymph node metastasis (OR = 3.07, 95% CI 2.23-4.23, P < 0.001) in the meta-analysis. It was found that the role of LINC00511 was overexpressed in breast cancer samples, and this overexpression was ascribed to a poor prognosis. The gain and loss-of-function tests demonstrated findings such as LINC00511 increased breast cancer cell proliferation, sphere-forming ability, and tumor growth. Additionally, the transcription factor E2F1 binds to the Nanog gene's promoter site to induce transcription. P57, P21, Prkca, MDM4, Map2k6, and FADD gene expression in the treatment group (LINC00511 deletion) was significantly higher than in the control group (P < 0.01). In addition, knockout cells had lower expression of BCL2 and surviving genes than control cells P < 0.001). In each of the two target alleles, the du-HITI approach introduced a reporter and a transcription termination signal. This strategy's donor vector preparation was significantly easier than "CRISPR HDR," and cell selection was likewise much easier than "CRISPR excision." Furthermore, when this approach was used in the initial transfection attempt, single-cell knockouts for both alleles were generated.

CONCLUSIONS

The methods employed and described in this work could be extended to the production of LINC00511 knockout cell lines and, in theory, to the deletion of other lncRNAs to study their function.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/e4b2fde01edf/12575_2022_171_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/f0d08e5b90e6/12575_2022_171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/2935aadddd21/12575_2022_171_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/b362cc0054ea/12575_2022_171_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/e2d1c90bbd15/12575_2022_171_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/92bd5825df59/12575_2022_171_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/e4b2fde01edf/12575_2022_171_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/f0d08e5b90e6/12575_2022_171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/2935aadddd21/12575_2022_171_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/b362cc0054ea/12575_2022_171_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/e2d1c90bbd15/12575_2022_171_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/92bd5825df59/12575_2022_171_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a80/9254607/e4b2fde01edf/12575_2022_171_Fig6_HTML.jpg
摘要

背景

随着对长链非编码RNA(lncRNA)检测的不断增加,需要应用功能研究方法,以便提供绝对精确、有益且可靠的处理信息,并产生有效的结果。我们利用基因敲除(KO)技术,在数名乳腺癌细胞患者中敲除长链基因间非编码RNA 00511基因,最后对结果进行了分析和检测。

结果

通过使用合并风险比(HR)及95%置信区间(CI)来衡量LINC00511表达模式的预测相关性。通过使用合并比值比(OR)及95%置信区间来衡量LINC00511表达谱与癌症转移之间的联系。该荟萃分析由15项研究组成,共纳入1040例肿瘤患者。我们使用三种不同的CRISPR/Cas9介导的敲低技术来阻止LINC00511 lncRNA转录。采用RT-PCR检测lncRNA和RNA表达。我们使用CCK-8、集落形成试验和侵袭性transwell试验来检测细胞增殖和侵袭。通过球形形成试验来检测干性。为验证分子结合情况,进行了荧光素酶报告基因检测。通过RT-qPCR、MTT和集落形成试验证实了LINC00511基因缺失对敲低乳腺癌细胞系的功能影响。该荟萃分析由15项试验组成,共纳入1040例恶性肿瘤患者。在荟萃分析中,LINC00511表达越高,总生存率越低(HR = 1.93,95% CI 1.49 - 2.49,P < 0.001),淋巴结转移比例越高(OR = 3.07,95% CI 2.23 - 4.23,P < 0.001)。研究发现,LINC00511在乳腺癌样本中呈过表达,这种过表达与预后不良有关。功能获得和缺失试验表明,LINC00511可增加乳腺癌细胞增殖、球形形成能力和肿瘤生长。此外,转录因子E2F1与Nanog基因的启动子位点结合以诱导转录。治疗组(LINC00511缺失)中P57、P21、Prkca、MDM4、Map2k6和FADD基因的表达明显高于对照组(P < 0.01)。此外,敲除细胞中BCL2和存活基因的表达低于对照细胞(P < 0.001)。在两个目标等位基因中,双同源靶向整合(du-HITI)方法引入了一个报告基因和一个转录终止信号。该策略的供体载体准备比“CRISPR HDR”明显更容易,细胞筛选也比“CRISPR切除”容易得多。此外,当在初次转染尝试中使用该方法时,可产生两个等位基因的单细胞敲除。

结论

本研究中采用和描述的方法可扩展至LINC00511敲除细胞系的构建,理论上也可用于其他lncRNA的缺失研究以探究其功能。

相似文献

1
CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes.CRISPR/Cas9介导的LINC00511基因敲除策略,通过抑制抗凋亡基因增加了乳腺癌细胞的凋亡。
Biol Proced Online. 2022 Jul 5;24(1):8. doi: 10.1186/s12575-022-00171-1.
2
Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.基于 CRISPR/Cas9 的基因组编辑方法:乳腺癌患者中 NOX4 表达的相关性,以及不同策略的 CRISPR/Cas9 敲除癌细胞中 Nox4 的效果评价。
BMC Cancer. 2023 Nov 27;23(1):1155. doi: 10.1186/s12885-023-11183-9.
3
Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.长链非编码 RNA LINC00511 通过诱导 miR-185-3p/E2F1/Nanog 轴促进乳腺癌肿瘤发生和干性。
J Exp Clin Cancer Res. 2018 Nov 27;37(1):289. doi: 10.1186/s13046-018-0945-6.
4
CRISPR/Cas9 Knockout Strategies to Ablate lncRNA Gene in Cancer Cells.用于在癌细胞中敲除长链非编码RNA基因的CRISPR/Cas9敲除策略。
Biol Proced Online. 2018 Nov 1;20:21. doi: 10.1186/s12575-018-0086-5. eCollection 2018.
5
Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.长链非编码 RNA LINC00511 的增加与肝癌的不良预后相关,并通过调节 miR-424 促进细胞增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3291-3301. doi: 10.26355/eurrev_201904_17691.
6
CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.CRISPR du-HITI 是一种有吸引力的靶向长链非编码 RNA HCP5 的方法,HCP5 是一种抑制卵巢癌细胞增殖的抑制因子。
Funct Integr Genomics. 2024 Mar 20;24(2):61. doi: 10.1007/s10142-024-01324-z.
7
Long non-coding RNA LINC00511 promotes proliferation, invasion, and migration of non-small cell lung cancer cells by targeting miR-625-5p/GSPT1.长链非编码RNA LINC00511通过靶向miR-625-5p/GSPT1促进非小细胞肺癌细胞的增殖、侵袭和迁移。
Transl Cancer Res. 2021 Dec;10(12):5159-5173. doi: 10.21037/tcr-21-1468.
8
Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.长链非编码 RNA LINC00511 通过调节 miR-185 对 STXBP4 的表达来参与乳腺癌的复发和放射抵抗。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7457-7468. doi: 10.26355/eurrev_201909_18855.
9
Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.长链基因间非编码RNA 511通过靶向微小RNA 618上调玛斯特罗(Maelstrom)的表达来促进骨肉瘤细胞的进展。
Aging (Albany NY). 2019 Aug 6;11(15):5351-5367. doi: 10.18632/aging.102109.
10
Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.长链非编码 RNA LINC00511 通过调控 miR-124-3p/EZH2 通路促进胃癌细胞增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4232-4245. doi: 10.26355/eurrev_202004_21003.

引用本文的文献

1
Investigating the effects of pcDNA3 polybia-MP1 on the apoptosis induction in lung cancer cell line.研究pcDNA3多比亚-MP1对肺癌细胞系凋亡诱导的影响。
Sci Rep. 2025 Aug 2;15(1):28226. doi: 10.1038/s41598-025-13439-9.
2
The emerging roles of LINC00511 in breast cancer development and therapy.LINC00511在乳腺癌发生发展及治疗中的新作用。
Front Oncol. 2024 Aug 14;14:1429262. doi: 10.3389/fonc.2024.1429262. eCollection 2024.
3
Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy.

本文引用的文献

1
Effects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed.含亚胺培南的尼森体纳米粒对高流行率耐甲氧西林表皮葡萄球菌生物膜形成的影响。
Sci Rep. 2022 Mar 24;12(1):5140. doi: 10.1038/s41598-022-09195-9.
2
Fabrication and Characterization of Thymol-Loaded Chitosan Nanogels: Improved Antibacterial and Anti-Biofilm Activities with Negligible Cytotoxicity.丁香酚载壳聚糖纳米凝胶的制备及性能表征:抗菌和抗生物膜活性提高,细胞毒性可忽略不计。
Chem Biodivers. 2022 Mar;19(3):e202100426. doi: 10.1002/cbdv.202100426. Epub 2022 Jan 27.
3
Stem cell therapy: A paradigm shift in breast cancer treatment.
长链非编码RNA(lncRNA)与E2F1相互作用的当前概念:为癌症治疗带来曙光。
Front Pharmacol. 2024 Jul 25;15:1432490. doi: 10.3389/fphar.2024.1432490. eCollection 2024.
4
(S)-3-(3,4-Dihydroxybenzyl) piperazine-2,5-dione (cyclo-Gly-L-DOPA or CG-Nio-CGLD) peptide loaded in Chitosan Glutamate-Coated Niosomes as anti-Colorectal cancer activity.壳聚糖谷氨酸涂层尼欧脂质体负载(S)-3-(3,4-二羟基苄基)哌嗪-2,5-二酮(环-Gly-L-DOPA 或 CG-Nio-CGLD)肽的抗结直肠癌活性。
BMC Pharmacol Toxicol. 2024 Aug 1;25(1):44. doi: 10.1186/s40360-024-00766-2.
5
Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.基于 CRISPR/Cas9 的基因组编辑方法:乳腺癌患者中 NOX4 表达的相关性,以及不同策略的 CRISPR/Cas9 敲除癌细胞中 Nox4 的效果评价。
BMC Cancer. 2023 Nov 27;23(1):1155. doi: 10.1186/s12885-023-11183-9.
6
Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy.长非编码 RNA:自噬介导的实体瘤药物耐药中的争议性作用。
Cancer Chemother Pharmacol. 2023 Dec;92(6):439-453. doi: 10.1007/s00280-023-04582-z. Epub 2023 Sep 28.
7
Long Non-coding RNAs and CRISPR-Cas Edition in Tumorigenesis.长链非编码RNA与CRISPR-Cas编辑在肿瘤发生中的作用
Adv Exp Med Biol. 2023;1429:41-58. doi: 10.1007/978-3-031-33325-5_3.
8
Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis.布鲁氏菌 abortus 抗原 omp25 疫苗:基于乳球菌 lactis 的开发和靶向。
Vet Med Sci. 2023 Jul;9(4):1908-1922. doi: 10.1002/vms3.1173. Epub 2023 Jun 5.
9
Long Non-Coding RNAs, Cell Cycle, and Human Breast Cancer.长非编码 RNA、细胞周期与人类乳腺癌。
Hum Gene Ther. 2023 Jun;34(11-12):481-494. doi: 10.1089/hum.2023.074.
10
A review on the role of LINC00511 in cancer.LINC00511在癌症中的作用综述。
Front Genet. 2023 Apr 14;14:1116445. doi: 10.3389/fgene.2023.1116445. eCollection 2023.
干细胞疗法:乳腺癌治疗中的范式转变。
World J Stem Cells. 2021 Jul 26;13(7):841-860. doi: 10.4252/wjsc.v13.i7.841.
4
Can We Routinely Employ the Use of Low-Pressure Gynaecological Laparoscopy? A Systematic Review.我们能否常规使用低压妇科腹腔镜检查?一项系统评价。
Cureus. 2021 May 31;13(5):e15348. doi: 10.7759/cureus.15348. eCollection 2021 May.
5
Causes of death among women with breast cancer: A follow-up study of 50 481 women with breast cancer in Finland.乳腺癌女性的死亡原因:芬兰50481名乳腺癌女性的随访研究
Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33607.
6
Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach.植物次生代谢产物对长链非编码RNA的调控:一种新型抗癌治疗方法。
Cancers (Basel). 2021 Mar 13;13(6):1274. doi: 10.3390/cancers13061274.
7
Plant stem cell research is uncovering the secrets of longevity and persistent growth.植物干细胞研究正在揭示长寿和持续生长的秘密。
Plant J. 2021 Apr;106(2):326-335. doi: 10.1111/tpj.15184. Epub 2021 Mar 25.
8
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.PI3K/AKT/mTOR 信号通路在乳腺癌中的作用:从分子特征到临床应用。
Int J Mol Sci. 2020 Dec 26;22(1):173. doi: 10.3390/ijms22010173.
9
m A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer.m 一种转移酶 METTL3 诱导的长链非编码 RNA ABHD11-AS1 促进了非小细胞肺癌的瓦博格效应。
J Cell Physiol. 2021 Apr;236(4):2649-2658. doi: 10.1002/jcp.30023. Epub 2020 Sep 6.
10
Long non-coding RNAs and transposable elements: A functional relationship.长链非编码核糖核酸与转座元件:一种功能关系。
Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118837. doi: 10.1016/j.bbamcr.2020.118837. Epub 2020 Aug 31.